Ethnic Disparities in Biomarker Testing and Targeted Therapy Use in Metastatic Lung Adenocarcinoma: A 2014-2021 Analysis

Alyssa Pereslete, Ahmad Ozair, Atulya Aman Khosla, Shreyas S Bellur, Charlie Hurmiz, Suresh Marada, Andrea McCracken, Mark Layton Watson, Manmeet Singh Ahluwalia

Real-world Response Endpoints in Patients With mNSCLC Treated With Chemotherapy Across Real-world Datasets

Brittany Avin McKelvey, Elizabeth Garrett-Mayer, Andrew J. Belli, Thomas D. Brown, Jessica Dow, Janet L. Espirito, Paul Kluetz, Xinran Ma, Andrea McCracken, Pallavi Shruti Mishra-Kalyani, Yanina Natanzon, Danielle Potter, Donna Rivera, Hillary Stires, Mark Stewart, Jeff Allen

EVALUATING THE IMPACT OF THE COVID-19 PANDEMIC ON THE DIAGNOSIS AND STAGING OF NEW BREAST CANCER CASES: A RETROSPECTIVE ANALYSIS OF MEDICAL CHART DATA FROM THE UNITED STATES

Knapp R,1 Hardtstock F,1 Wilke T,2 Boner B,3 Hurmiz C,3 McCracken A3
1Cytel Inc., Berlin, Germany, 2IPAM e.V., Wismar, Germany, 3 Guardian Research Network, Spartanburg, SC, USA

A Population Pharmacokinetic Model of High Dose Methotrexate in Adults with Cancer Identifies Baseline Albumin, Body Weight, and Time-dependent Creatinine as Predictors of Acute Kidney Injury

S. Howard, M. Ibarra,² R. Combs, and P. Schaiquevich

Insights from a pharmacometric analysis of HDMTX in adults with cancer: clinically relevant covariates for application in precision dosing

Manuel Ibarra,Ryan Combs,Zachary L. Taylor,Laura B. Ramsey,Torben Mikkelsen,Randal K. Buddington,Jesper Heldrup,Jason N. Barreto,Martin Guscott,Jennifer Lowe,Charles Hurmiz,Suresh Marada,Scott C. Howard,Paula Schaiquevich

Clinical Characteristics and Infection-Related Outcomes in Patients with Lymphoid Malignancies with or without Secondary Immunodeficiencies: Results from a Retrospective Multi-Database Study

Treatment Patterns of Patients With Soft Tissue Sarcoma Progressing to Third Line of Therapy

Vicki K. Wing MS, Philippe Martin MS, MBA, Aaron Galaznik MD, MBA, Li Shi MA, Emelly Rusli MPH, Lilia Bouzit MS, Chelsea Vigna MPH, Caleb Ball BS, and Rahul Jain PhD

Leveraging the integrated EHR for trial matching across a nationwide network

Timothy Joseph Yeatman, Mark Watson, Adam Chasse

Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations

Nina Shah ¹, Matthew Sussman ², Concetta Crivera ³, Satish Valluri ³, Jennifer Benner ⁴, Sundar Jagannath ⁵

Photo by Diane Serik

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

Sundar Jagannath, Yi Lin, Hartmut Goldschmidt, Donna Reece, Ajay Nooka, Alicia Senin, Paula Rodriguez-Otero, Ray Powles, Kosei Matsue, Nina Shah, Larry D. Anderson Jr, Matthew Streetly, Kimberly Wilson, Hoa Van Le, Arlene S. Swern, Amit Agarwal & David S. Siegel

Photo by Scott Graham